Corpus Intelligence IC Memo — ADVENTHEALTH WESLEY CHAPEL 2026-04-26 13:55 UTC
IC Memo — ADVENTHEALTH WESLEY CHAPEL
Investment Committee Memorandum | FL | 169 beds | Grade C | EBITDA uplift $26.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVENTHEALTH WESLEY CHAPEL

CCN 100319 | nan, FL | 169 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ADVENTHEALTH WESLEY CHAPEL is a 169-bed suburban community hospital in nan, FL with $360.1M in net patient revenue and a 17.0% operating margin. The hospital serves a payer mix of 23.8% Medicare, 1.5% Medicaid, and 74.6% commercial.

Thesis: Turnaround. Our ML models identify $26.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.0% to 24.4% (+736bps).

Net Revenue HCRIS$360.1M
Current EBITDA COMPUTED$61.2M
Operating Margin COMPUTED17.0%
Occupancy HCRIS68.2%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS18.6%
Distress Probability ML40.8%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
121
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 17.0% places it above the state median. Among 121 size-comparable peers (84-338 beds), the median margin is 2.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-338), prioritizing same-state peers. 121 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTHEALTH WESLEY CHAPEL (Target)FL169$360.1M17.0%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
ADVENTHEALTH DAYTONA BEACHFL330$532.7M-1.9%
CCF HOSPITAL - WESTONFL258$465.4M-3.8%
DELRAY MEDICAL CENTERFL324$453.3M12.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $26.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.6M+210bp18mo
Cost to Collect4.5%2.5%$7.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.4M+122bp9mo
Clean Claim Rate88.0%96.0%$230K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.6M
Cost to Collect
$7.2M
Denial Rate Reduction
$7.1M
A/R Days Reduction
$4.4M
Clean Claim Rate
$230K
Total EBITDA Uplift$26.5M
Current EBITDA$61.2M
+ RCM Uplift+$26.5M
Pro Forma EBITDA$87.7M
Current Margin17.0%
Pro Forma Margin24.4%
WC Released (1x)$13.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$94.2M$668.8M7.10x48.0%
Base (11x exit)10.0x11.0x$94.2M$766.2M8.14x52.1%
Bull Case9.0x11.0x$84.7M$884.3M10.43x59.8%
Bull (12x exit)9.0x12.0x$84.7M$989.7M11.68x63.5%
Bear Case11.0x10.0x$103.6M$505.7M4.88x37.3%
Bear (11x exit)11.0x11.0x$103.6M$589.9M5.69x41.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 121 hospitals with 84-338 beds
  • Same-state prioritization (n=122)
  • Comp margins: P25=-6.5% / P50=2.7% / P75=14.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.